Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
In a recent transaction reported to the Securities and Exchange Commission, Jana Barsten, a director at Ziff Davis, Inc. (NASDAQ:ZD), acquired 1,000 shares of common stock. The shares were purchased at a price of $38.08 each, totaling $38,080. The timing is notable as the stock trades near its 52-week low of $37.76, having declined about 9% in the past week. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value model. Following this transaction, Barsten’s direct ownership in the company increased to 4,347 shares. This purchase reflects Barsten’s continued investment in Ziff Davis, a company that operates in the technology and communications sector. The insider purchase aligns with broader company actions, as management has been actively buying back shares. InvestingPro subscribers can access 14 additional investment tips and a comprehensive Pro Research Report for deeper analysis of ZD’s potential.
In other recent news, Ziff Davis Inc. reported its Q4 2024 financial results, revealing an adjusted diluted earnings per share (EPS) of $2.58, slightly above the forecast of $2.57. However, the company reported revenue of $412.8 million, which fell short of the expected $423.87 million, contributing to a mixed market reaction. For the full year, Ziff Davis achieved a revenue of $1.401 billion, marking a 2.8% increase from the previous year. The company’s adjusted EBITDA for the quarter was $171.8 million, reflecting a 2.5% year-over-year growth.
Additionally, Ziff Davis has introduced a new segment reporting structure, aimed at providing greater transparency into its business operations. The company anticipates growth across all five of its segments in 2025, driven by new product launches and strategic initiatives. Citi analysts recently adjusted their outlook on Ziff Davis, reducing the price target from $58.00 to $52.00 while maintaining a Neutral rating. Despite acknowledging some progress, Citi highlighted ongoing challenges and potential risks, particularly concerning GenAI Search.
The company also emphasized its focus on margin expansion and profitability, with management expressing confidence in an upswing for all business segments. Ziff Davis plans to continue its M&A strategy, supported by a strong balance sheet, to drive future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.